Tag: PDT | Page 6 | Modulight

Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging

Scientific papers / 690 nm, in vitro, in vivo, IRDye700, IRDye700DX, ML7710, PDT, preclinical, targeted cancer PDT, targeted therapies / January 20, 2020

Published in: Theranostics Authors: Henriette S. de Bruijn, Vida Mashayekhi, Tom J.L. Schreurs, Pieter B.A.A. van Driel, Gustav J. Strijkers, Paul J. van Diest, Clemens W.G.M. Lowik, Ann L.B. Seynhaeve, Timo L.M. ten Hagen, Jeanine J. Prompers, Paul M.P. van Bergen en Henegouwen, Dominic J. Robinson, Sabrina Oliveira

Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging Read More »

Porphyrin-lipid assemblies and nanovesicles overcome ABC transporter-mediated photodynamic therapy resistance in cancer cells

Scientific papers / 690 nm, benzoporphyrin derivative, BPD, breast, in vitro, ML6600, ML8500, PDT, Photodynamic therapy, photosensitizer / August 10, 2019

Published in: Cancer Letters Authors: Yan Baglo, Barry J. Liang, Robert W. Robey, Suresh V. Ambudkar, Michael M. Gottesman, Huang-Chiao Huang

Porphyrin-lipid assemblies and nanovesicles overcome ABC transporter-mediated photodynamic therapy resistance in cancer cells Read More »

Modulight becomes exclusive supplier for BAUSCH + LOMB

Press Releases / 689 nm laser, B+L, medical laser, ML6710i, ophthalmology, PDT, pharmaceutical company, Photodynamic therapy, Visudyne, Visudyne laser / December 4, 2018

BRIDGEWATER, N.J., December 04, 2018 – Bausch + Lomb, a leading global eye health company, and Modulight, Inc., a designer and manufacturer of lasers and optics for personalized medicine, announced the companies have entered into an exclusive agreement to collaborate and develop a new photodynamic laser specifically designed for use with Bausch + Lomb’s VISUDYNE® (verteporfin for injection) therapy.

Modulight becomes exclusive supplier for BAUSCH + LOMB Read More »

Irradiance controls photodynamic efficacy and tissue heating in experimental tumours: implication for interstitial PDT of locally advanced cancer

Scientific papers / 630 nm, Barrett's esophagus, esophageal cancer, H&N cancer, head & neck cancer, high-grade dysplasia, in vivo, iPDT, Lung cancer, ML6600, ML7710, PDT, photofrin, preclinical / October 24, 2018

Published in: British Journal of Cancer Authors: Gal Shafirstein, David A. Bellnier, Emily Oakley, Sasheen Hamilton, Michael Habitzruther, Lawrence Tworek, Alan Hutson, Joseph A. Spernyak, Sandra Sexton, Leslie Curtin, Steven G. Turowski, Hassan Arshad, Barbara Henderson

Irradiance controls photodynamic efficacy and tissue heating in experimental tumours: implication for interstitial PDT of locally advanced cancer Read More »

The effect of light sensitizer localization on the stability of indocyanine green liposomes

Scientific papers / 808 nm, in vitro, liposomes, MLAKIT, PDT / August 28, 2018

Published in: Journal of Controlled Release Authors: Tatu Lajunen, Riikka Nurmi, Danny Wilbie, Teemu Ruoslahti, Niklas G. Johansson, Ossi Korhonen, Tomasz Rog, Alex Bunker, Marika Ruponen, Arto Urtti

The effect of light sensitizer localization on the stability of indocyanine green liposomes Read More »

An Infrared Dye–Conjugated Virus-like Particle for the Treatment of Primary Uveal Melanoma

Scientific papers / 690 nm, choroidal melanoma, in vitro, in vivo, IRDye700, ML6600, MLAKIT, ophthalmology, PDT, tumor, Uveal Melanoma / February 1, 2018

Published in: Molecular Cancer Therapeutics Authors: Rhonda C. Kines, Isabella Varsavsky, Sanghamitra Choudhary, Debaditya Bhattacharya, Sean Spring, Roger McLaughlin, Shin J. Kang, Hans E. Grossniklaus, Demetrios Vavvas, Stephen Monks, John R. MacDougall, Elisabet de los Pinos, and John T. Schiller

An Infrared Dye–Conjugated Virus-like Particle for the Treatment of Primary Uveal Melanoma Read More »

WST11 Vascular Targeted Photodynamic Therapy Effect Monitoring by Multispectral Optoacoustic Tomography (MSOT) in Mice

Scientific papers / 753 nm, ML7710, PDT, Photodynamic therapy, preclinical, renal cancer, Tookad, vascular-targeted PDT, WST11 / January 1, 2018

Published in: Theranostics Authors: Volker Neuschmelting, Kwanghee Kim, Jaber Malekzadeh-Najafabadi, Sylvia Jebiwott, Jaya Prakash, Avigdor Scherz, Jonathan A. Coleman, Moritz F. Kircher, Vasilis Ntziachristos

WST11 Vascular Targeted Photodynamic Therapy Effect Monitoring by Multispectral Optoacoustic Tomography (MSOT) in Mice Read More »

Photodynamic therapy for the treatment of atherosclerotic plaque: Lost in translation

Scientific papers / ML7710, PDT, Photodynamic therapy / November 28, 2016

Published in: Cardiovascular therapeutics Authors: Manish Jain, Matthieu Zellweger, Georges Wagnières, Hubert van den Bergh, Stéphane Cook, Marie-Noelle Giraud

Photodynamic therapy for the treatment of atherosclerotic plaque: Lost in translation Read More »

EGFR targeted nanobody–photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer

Scientific papers / 690 nm, H&N cancer, head & neck cancer, IRDye700, ML7710, PDT, Photodynamic therapy, preclinical, targeted therapies / May 10, 2016

Published in: Journal of Controlled Release Authors: Pieter B.A.A. van Driel, Martin C. Boonstra, Maxime D. Slooter, Raimond Heukers, Marieke A. Stammes, Thomas J.A. Snoeks, Henriette S. de Bruijn, Paul J. van Diest, Alexander L. Vahrmeijer, Paul M.P. van Bergen en Henegouwen, Cornelis J.H. van de Velde, Clemens W.G.M. Löwik, Dominic J. Robinson, Sabrina Oliveira

EGFR targeted nanobody–photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer Read More »